NCT05580211View on ClinicalTrials.gov

Neuromodulation for Schizophrenia

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

October 30, 2025

Study Completion Date

January 30, 2026

Conditions
Schizophrenia
Interventions
DEVICE

Non-invasive brainstem modulation device (stimulation Randomized)

Study participants will receive \~19-minute treatments twice daily in the clinic setting over 4 weeks using a non-invasive brainstem modulation device.

DEVICE

Non-invasive brainstem modulation device (stimulation-Open Label)

Study participants will receive \~19-minute treatments twice daily in the clinic setting over 8 weeks using a non-invasive brainstem modulation device.

Trial Locations (1)

Unknown

RECRUITING

Centre for Addiction and Mental Health, Toronto

Sponsors

Lead Sponsor

Scion NeuroStim
All Listed Sponsors
collaborator

Centre for Addiction and Mental Health

OTHER

lead

Scion NeuroStim

INDUSTRY